Rifampin plus pyrazinamide is no longer recommended for treating latent tuberculosis
Rifampin plus pyrazinamide is no longer recommended for treating latent tuberculosis...due to concerns about hepatotoxicity.
This combination was added to the TB recommendations in 2000.
The big advantage is that it's given for only 2 to 3 months...compared to 4 to 9 months for the other drug regimens.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote